Genmab — Februar 2018
-
God morgen.
-
God morgen
-
Hold da op en masse overskifter om blodrøde dage. Faktum er vel at Japan kun er nede med 2 % - Kina har langt hen af vejen kørt deres aktiemarked afkoblet fra europæisk. Ingen stigende rente i europa og stadig simuli fra ECB. Mon ikke vi overlever denne gang også.
-
Enig Solsen.
-
Der er noget på Børsen om robotter og automatreaktioner hvilket giver god mening, så er enig med dig Solsen.
-
GM, from twitter: Ola Landgren, M.D. @DrOlaLandgren
@sloan_kettering has a few available slots open on phase 2 study using a 4-drug combo (Daratumumab + Carfilzomib + Revlimid + Dexamethasone), open for newly diagnosed multiple myeloma patients. Amazing therapy! Preliminary results are very promising. @IMFmyeloma @theMMRF #mmsm -
Det er vist det man kan kalde en meget bred kombi.
-
Den kombi må da være mega dyr!
-
yes, started recruiting last year, think this is the one
https://clinicaltrials.gov/ct2/show/NCT03290950?term=Daratumumab+%2B+Carfilzomib+%2B+Revlimid+%2B+Dexamethasone&rank=1 ; found it interesting that he sounds very enthusiastic about it -
Enig EL.
-
Send det gerne allerede nu.
-
1.040 testes ovenfra. Klarede sig fint de første minutter.
-
De første 7 minutter.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind